Little Chance Congress Clears 340B Overhaul in 2023—Unless Courts Act, Say Lobbyists

Capitol building
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program.
Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023, unless spurred by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lawmaker Sponsoring 340B Transparency Bill Honored by PhRMA-Provider Group

Buschon ASAP 340B award
Rep. Larry Bucshon (R-Indiana) received the "Saving America’s 340B Program Leadership Award" award from ASAP 340B.
The congressional sponsor of legislation that would require hospitals and potentially other covered entities to publicly report their 340B revenue, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Center Leaders Urge Boards to Push State, Federal Support of 340B

CHI Expo
The National Association of Community Health Centers’ CHI and Expo addressed the advocacy role of health center boards of directors.
The boards of directors of health centers need to take on a bigger advocacy role in support of the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Urges Dropping Bill Language to Exclude Generic Injectables from 340B

American Hospital Association logo
The American Hospital Association (AHA), 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers urged a federal judge to reject Novartis’ attempt to block Maryland’s new 340B contract pharmacy access law.
The nation’s largest hospital advocacy organization urged legislators to drop a provision from draft legislation that would exclude generic injectables [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Provider-PhRMA Coalition Adds Civil Rights Group

ASAP 340B
ASAP 340B, a coalition of a drug industry trade group and a community health center organization, added a civil rights group to its membership.
An alliance led by a powerful drug industry trade group and community health center organization that is pushing for 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

From the Publisher & CEO: The Big Question on the Minds of Every 340B Stakeholder

DC court of appeals
340B stakeholders are anticipating two major contract pharmacy judicial rulings, including one from the Court of Appeals for the District of Columbia.
Amid nationwide uncertainty over both the legality of the scope of the 340B contract pharmacy program and the legality of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Maker Owes 340B Providers Repayment, HRSA Pending Audit Finds

Nephron Pharmaceuticals
A HRSA fiscal year 2023 audit tentatively found that drug maker Nephron Pharmaceuticals owes 340B repayments to providers.
The first posted fiscal year 2023 audit of a drug maker tentatively found the company owes repayments to providers. The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Drugs Among Those at Tornado-Hit Facility Requiring Direct Purchase

Pfizer headquarters
Pfizer has limited multiple 340B-eligible drugs to direct purchase after a tornado damaged one of the drug maker's manufacturing facilities.
Federal officials confirmed that 340B-eligible drugs are among the 12 medications pharmaceutical manufacturer Pfizer has limited to direct purchase after [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Three Terminations, 10 Paybacks to Manufacturers in HRSA’s 2023 Pending Provider Audits

HRSA provider audits
HRSA audits found terminations were required for a 340B provider site and a contract pharmacy and that another provider owed repayments to drugmakers.
Three provider organizations may have contract pharmacies terminated from the 340B program and 10 providers would owe repayments to drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Activity Experiences Historic Surge

Capitol building
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program.
The hiring of lobbyists in the congressional legislative fight over 340B was dominated by pharmaceutical firms and provider-manufacturer alliances in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live